文献速递新生儿儿童感染儿童消化与营养

母亲产前抗生素暴露对早产儿疾病的影响

The Impact of Maternal Antibiotics on Neonatal Disease.
PubMed 文献 · J Pediatr · 2018-03-16

该研究基于580例胎龄<32周早产儿的现成队列进行二次分析,发现产前72小时内母亲抗生素暴露与坏死性小肠结肠炎(NEC)和死亡风险降低相关,但与晚发型脓毒症(LOS)无显著关联;出生后高时长经验性抗生素暴露与死亡风险增加相关。

要点

  • 产前抗生素暴露与早产儿NEC风险降低相关(OR 0.28)。
  • 产前抗生素暴露与早产儿死亡风险降低相关(OR 0.29)。
  • 出生后高时长经验性抗生素暴露与死亡风险增加相关(OR 3.18)。

核心结论

  • 产前抗生素暴露与早产儿NEC或死亡发生率降低相关,其对婴儿结局的影响值得进一步研究。

研究设计与样本

  • 通过580例胎龄<32周、入组3个III级新生儿重症监护室的早产儿现成队列进行二次数据分析。

主要发现

  • 研究婴儿中NEC发生率为7.5%,LOS为11.1%,死亡为9.6%,NEC、LOS或死亡复合结局为21.3%。
  • 调整胎龄、出生后经验性抗生素暴露等因素后,产前抗生素暴露与NEC风险降低相关(OR 0.28;95%CI 0.14-0.56;P<.001)。
  • 产前抗生素暴露与死亡风险降低相关(OR 0.29;95%CI 0.14-0.60;P=.001),但与LOS无显著关联(OR 1.59;95%CI 0.84-2.99;P=.15)。
  • 产前抗生素暴露对复合结局的保护作用显著(OR 0.52,P<.001)。
  • 高时长出生后经验性抗生素暴露与死亡风险增加相关(OR 3.18,P=.002),与其他结局无关。

关键数值与推荐

  • 产前抗生素暴露定义为母亲在分娩前72小时内接受抗生素。
  • 出生后经验性抗生素暴露定义为生后第一天内无明确感染证据时启动抗生素,分为低时长(<5天)或高时长(>5天)。
  • 三分之二的母亲在分娩前72小时内接受抗生素,其中59.8%接受>1种抗生素。
  • 最常用的抗生素为氨苄西林(37.6%)和阿奇霉素(26.4%)。

临床怎么用

  • 对于胎龄<32周早产儿,母亲产前72小时内抗生素暴露可能与NEC和死亡风险降低相关。
  • 出生后无明确感染证据时,高时长(>5天)经验性抗生素暴露与死亡风险增加相关,应审慎评估抗生素使用时长。

局限性

  • 本研究为现成队列的二次数据分析。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We examined the impact of prenatal exposure to maternal antibiotics on risk of necrotizing enterocolitis (NEC), late onset sepsis (LOS), and death in infants born preterm. STUDY DESIGN: Secondary data analysis was conducted via an extant cohort of 580 infants born <32 weeks of gestation and enrolled in 3 level III neonatal intensive care units. Prenatal antibiotic exposure was defined as antibiotics received by the mother within 72 hours before delivery. Postnatal empiric antibiotic exposure was defined as antibiotic initiated within the first day of life without documented infection, categorized as low (<5 days) or high (>5 days) duration. RESULTS: Two-thirds of mothers received antibiotics within 72 hours before delivery, of whom 59.8% received >1 antibiotic. Ampicillin (37.6%) and azithromycin (26.4%) were the most common antibiotics given. NEC occurred in 7.5%, LOS in 11.1%, death in 9.6%, and the combined outcome of NEC, LOS, or death in 21.3% of study infants. In multiple logistic regression models adjusted for gestational age, postnatal empiric antibiotic exposure, and other factors, prenatal antibiotic exposure was associated with reduced risk of NEC (OR 0.28; 95% CI 0.14-0.56; P < .001), death (OR 0.29; 95% CI 0.14-0.60; P = .001), but not LOS (OR 1.59; 95% CI 0.84-2.99; P = .15), although protection was significant for the combined outcome (OR 0.52, P < .001). High postnatal empiric antibiotic exposure was associated with greater risk of death but not other outcomes in multiple regression models (OR 3.18, P = .002). CONCLUSIONS: Prenatal antibiotic exposure was associated with lower rates of NEC or death of infants born preterm, and its impact on infant outcomes warrants further study.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Reed BD, Schibler KR, Deshmukh H, et al. The Impact of Maternal Antibiotics on Neonatal Disease. J Pediatr. 2018. PMID: 29551319. doi:10.1016/j.jpeds.2018.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。